Protalix BioTherapeutics, Inc. (NYSE:PLX) has 98 institutional investors that have filed 13F reports for the period ending March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 3,616,962 | -30,144 | -0.83% | $7,848,807.00 |
| MAK CAPITAL ONE LLC | 31 Mar, 2026 | 3,544,139 | 3,544,139 | 0.00% | $7,690,782.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 1,224,800 | -38,500 | -3.05% | $2,657,816.00 |
| State Street Corp | 31 Mar, 2026 | 972,815 | 387,554 | 66.22% | $2,111,009.00 |
| Northern Trust Corp | 31 Mar, 2026 | 885,448 | 19,740 | 2.28% | $1,921,422.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 865,298 | 35,244 | 4.25% | $1,877,696.00 |
| Stratos Wealth Partners, LTD. | 31 Mar, 2026 | 500,000 | 0 | 0.00% | $1,085,000.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 432,485 | 432,485 | 0.00% | $938,492.00 |
| Prospera Financial Services Inc | 31 Mar, 2026 | 418,570 | 418,570 | 0.00% | $908,272.00 |
| Opaleye Management Inc. | 31 Mar, 2026 | 340,000 | -4,616,352 | -93.14% | $737,800.00 |
| Morgan Stanley | 31 Mar, 2026 | 301,793 | 169,806 | 128.65% | $654,890.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 296,843 | 268,099 | 932.71% | $643,789.00 |
| UBS Group AG | 31 Mar, 2026 | 265,535 | 3,015 | 1.15% | $576,211.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 251,345 | -274,273 | -52.18% | $545,418.00 |
| Bank of New York Mellon Corp | 31 Mar, 2026 | 219,307 | 8,440 | 4.00% | $475,896.00 |
| Connor, Clark & Lunn Investment Management Ltd. | 31 Mar, 2026 | 207,275 | -24,818 | -10.69% | $449,787.00 |
| Round Rock Advisors LLC | 31 Mar, 2026 | 192,080 | -118,124 | -38.08% | $416,814.00 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 189,100 | 0 | 0.00% | $410,347.00 |
| EVERGREEN CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 171,338 | 171,338 | 0.00% | $371,804.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Mar, 2026 | 159,311 | -15,759 | -9.00% | $345,705.00 |